Related Experiment Video
Updated: Jan 1, 2026

08:05
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
10.1K
Summary
CC-486, an oral hypomethylating agent, improved survival and delayed relapse in older acute myeloid leukemia patients in remission after chemotherapy. This oral azacitidine offers a new treatment option for this patient group.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- Induction chemotherapy is standard for achieving remission in AML.
- Maintaining remission and preventing relapse are critical challenges in AML management.
Discussion:
- CC-486, an oral formulation of azacitidine, is a DNA hypomethylating agent.
- This study investigated the efficacy of CC-486 in older AML patients post-induction chemotherapy.
- The study assessed overall survival and time to relapse as primary endpoints.
Key Insights:
- CC-486 significantly extended overall survival in older AML patients who achieved remission.
- Treatment with CC-486 also delayed the time to relapse in this patient cohort.
- Oral azacitidine demonstrates potential as a maintenance therapy in AML.
Outlook:
- Further research may explore CC-486 in different AML patient populations.
- CC-486 could represent a valuable oral therapeutic option for AML maintenance.
- Long-term safety and efficacy data will be crucial for clinical adoption.
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.1K
Drug Therapy
219
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
219
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Drug Dosage Regimen: Overview
4.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.3K
Drugs Used in Lower Respiratory Disorders: Overview
961
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
961
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K

